An angiogenic role for the human peptide antibiotic LL-37/hCAP-18.

By R. Koczulla, G. von Degenfeld, C. Kupatt, F. Krötz, S. Zahler, T. Gloe, Katja Issbrücker, P. Unterberger, M. Zaiou, C. Lebherz and 10 more. Journal of Clinical Investigation, 2003

882 citations recorded by the source corpus.

Subfields: Microbiology, Molecular Biology, Oncology

View Paper: https://www.semanticscholar.org/paper/78003b44209dcfddbb67b4db9835e891573d5e56

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Microbiology

1. S. Gellatly
2. Amy T. Y. Yeung
3. H. Jenssen
4. P. Hamill
5. Robert E. W. Hancock

In Molecular Biology

1. S. Gellatly
2. Amy T. Y. Yeung
3. N. Borregaard
4. Robert E. W. Hancock
5. H. Jenssen
6. C. Serhan

In Oncology

1. C. Gerard

Citations in the corpus

• Peptide Antimicrobial Agents (2006, background): “promote angiogenesis (129), and induce wound repair (36).”
• Multifunctional cationic host defence peptides and their clinical applications (2011, background): “[48] demonstrated that LL-37 activated vessel growth in cultivated epithelial cells in a chorioallantoic membrane assay.”
• Neutrophil granules: a library of innate immunity proteins. (2007, background): “In endothelialcells, LL-37 seemsto have a direct growth-promoting effect and the ability to induce angiogenesis [ 50 ].”
• International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) Family (2009, background): “Decreased vascularization during wound repair observed in mice deficient for CRAMP indicates that cathelicidin-mediated angiogenesis is important for cutaneous wound neovascularization in vivo (Koczulla et al., 2003).”